Johan W. Jonker

14.1k citations

102 papers · 10.3k indexed · 5 hit papers · h-index 43

Impact in

Oncology top 0.2%
- Drug Transport and Resistance Mechanisms
Pediatrics, Perinatology and Child Health top 0.2%
- Pharmacological Effects and Toxicity Studies

Papers in

Oncology 45
- Drug Transport and Resistance Mechanisms 43
Pediatrics, Perinatology and Child Health 27
- Pharmacological Effects and Toxicity Studies 21

Co-authors: Alfred H. Schinkel Els Wagenaar Michael Downes Gracia Merino Antonius E. van Herwaarden Ronald M. Evans Jos H. Beijnen Ruth T. Yu
Journals: Scientific Reports (5 papers)Proceedings of the National Academy of Sciences (5 papers)Nature (4 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Molecular Pharmacology (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Johan W. Jonker

100 papers receiving 10.2k citations

Hit Papers

5 papers align trajectories log scale

Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation 2015 · 881 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Diabetes
2012 Advanced Drug Delivery Reviews
2003 Advanced Drug Delivery Reviews
2002 Proceedings of the National Academy of Sciences
2000 JNCI Journal of the National Cancer Institute

Peers

Countries citing papers authored by Johan W. Jonker

Since Specialization

Citations

This map shows the geographic impact of Johan W. Jonker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan W. Jonker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan W. Jonker more than expected).

Fields of papers citing papers by Johan W. Jonker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan W. Jonker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan W. Jonker. The network helps show where Johan W. Jonker may publish in the future.

Co-authors

The 25 scholars most cited alongside Johan W. Jonker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan W. Jonker Line = papers co-authored together Johan W. Jonker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Supplementation of Seaweed Extracts to the Diet Reduces Symptoms of Alzheimer’s Disease in the APPswePS1ΔE9 Mouse Model Nutrients ·松本健, Na Zhan, A. Zając, Frank Leijten, 代修鹏, Martien P. M. Caspers, Assia Tiane, Silvia Friedrichs, Yanlin Li, Branislav Radovic, Gardi Voortman, Francesca Zimetti, Dick Jaarsma, Lars Verschuren, Johan W. Jonker, Folkert Kuipers, Dieter Lütjohann, Tim Vanmierlo, Monique Mulder	2024	6
2	Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer’s Disease? Nutrients ·松本健, Na Zhan, Gardi Voortman, Frank Leijten, 林野庁研究普及課教育班, Brij Kishor Pal, M-C. Caloz-Tschopp, Michiel Huybrechts, Hongbing Liu, Johan W. Jonker, Folkert Kuipers, Dieter Lütjohann, Tim Vanmierlo, Monique Mulder	2023	10
3	Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases International Journal of Molecular Sciences ·Na Zhan, Jacoba Talmona, 松本健, Yankai Liu, 良夫美濃, Gardi Voortman, Jeroen van Rooij, Frank Leijten, Tim Vanmierlo, Folkert Kuipers, Johan W. Jonker, Vincent W. Bloks, Dieter Lütjohann, 代修鹏, Francesca Zimetti, Maria Pia Adorni, Hongbing Liu, Monique Mulder	2023	10
4	The Apical Sodium-Dependent Bile Acid Transporter in Cholangiocytes Is Not Required for the Generation of Bile Flow in Mice SHILAP Revista de lepidopterología ·Anna Bertolini, Ivo P. van de Peppel, Rick Havinga, Johan W. Jonker, Henkjan J. Verkade	2022	0
5	Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism Scientific Reports ·Metin Çiçek, Vincent W. Bloks, Dicky Struik, Nicolette Huijkman, Niels Kloosterhuis, Justina C. Wolters, Ronald J. A. Wanders, Frédéric M. Vaz, Markus Islinger, Folkert Kuipers, Bart van de Sluis, Albert K. Groen, Henkjan J. Verkade, Johan W. Jonker	2022	8
6	Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in HepatocytesSummary SHILAP Revista de lepidopterología ·Ali Saeed, Paulina Bartuzi, Janette Heegsma, Daphne Dekker, Niels Kloosterhuis, Alain de Bruin, Johan W. Jonker, Bart van de Sluis, Klaas Nico Faber	2021	57
7	Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia Scientific Reports ·Steffen Seitz, Henkjan J. Verkade, Anna Bertolini, Sanne de Wit, Elvira Mennillo, Oduardo, André Alberto Weber, Rick Havinga, A. Raynal, Jana Jašprová, Dicky Struik, Vincent W. Bloks, Shujuan Chen, 旬恵藤井, Libor Vı́tek, Robert H. Tukey, Johan W. Jonker	2021	16
8	Short‐term protein restriction at advanced age stimulates FGF21 signalling, energy expenditure and browning of white adipose tissue FEBS Journal ·Татьяна Алексеевна Тимкина, Metin Çiçek, Marcel A. Vieira‐Lara, Theo H. van Dijk, Henk Wolters, Mirjam H. Koster, Albert Gerding, Ronald van Os, Vincent W. Bloks, Barbara M. Bakker, Janine K. Kruit, Johan W. Jonker	2020	21
9	Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis Hepatology ·Anna Bertolini, Ivo P. van de Peppel, Frank A.J.A. Bodewes, Han Moshage, Alberto Fantin, Fabio Farinati, Romina Fiorotto, Johan W. Jonker, Mario Strazzabosco, Henkjan J. Verkade, Giulia Peserico	2020	195
10	Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application Current Opinion in Lipidology ·Dicky Struik, Татьяна Алексеевна Тимкина, Johan W. Jonker	2019	49
11	Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice Cellular and Molecular Gastroenterology and Hepatology ·Pauline T. Ikpa, Du-Rim Eo, Agnieszka Timorek, Mohd Fazdli, Henkjan J. Verkade, Johan W. Jonker, Hugo R. de Jonge, Marcel J. C. Bijvelds	2019	11
12	Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis Journal of Cystic Fibrosis ·Ivo P. van de Peppel, Frank A.J.A. Bodewes, Henkjan J. Verkade, Johan W. Jonker	2018	27
13	TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans International Journal of Obesity ·Vera J. M. Nies, Dicky Struik, Marcel G. M. Wolfs, Sander S. Rensen, Ewa Szalowska, Unga A. Unmehopa, Kees Fluiter, Thomas P. van der Meer, 卓国卫, Wim A. Buurman, Júlia María D’Andréa Greve, Farhad Rezaee, Ronit Shiri‐Sverdlov, Roel J. Vonk, Dick F. Swaab, Bruce H. R. Wolffenbuttel, Johan W. Jonker, Jana V. van Vliet‐Ostaptchouk	2017	15
14	NF-κB p65 serine 467 phosphorylation sensitizes mice to weight gain and TNFα-or diet-induced inflammation Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Masato Iwahashi, Татьяна Алексеевна Тимкина, Tobias Wijshake, Janine K. Kruit, Nicolette Huijkman, Daphne Dekker, Mirjam H. Koster, Niels Kloosterhuis, Debby P.Y. Koonen, Alain de Bruin, Darren J. Baker, Marten H. Hofker, Jan van Deursen, Johan W. Jonker, M. Lienhard Schmitz, Bart van de Sluis	2017	9
15	IVACAFTOR RESTORES THE ENTEROHEPATIC FEEDBACK REGULATION OF THE BILE ACID HOMEOSTASIS IN PATIENTS WITH A CFTR G551D MUTATION Pediatric Pulmonology ·Frank A.J.A. Bodewes, Du-Rim Eo, B. D. Collins, Claude van der Ley, Johan W. Jonker, Henkjan J. Verkade	2015	2
16	Hepatic Farnesoid X-Receptor Isoforms α2 and α4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice PLoS ONE ·Marije Boesjes, Vincent W. Bloks, Jurre Hageman, Trijnie Bos, Theo H. van Dijk, Rick Havinga, Henk Wolters, Johan W. Jonker, Folkert Kuipers, Albert K. Groen	2014	29
17	Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer Nature ·Jae Myoung Suh, Johan W. Jonker, Maryam Ahmadian, Regina Goetz, Denise E. Lackey, Olivia Osborn, Zhifeng Huang, Weilin Liu, Eiji Yoshihara, Theo H. van Dijk, Rick Havinga, Weiwei Fan, Yunqiang Yin, Ruth T. Yu, Christopher Liddle, Annette R. Atkins, Jerrold M. Olefsky, Moosa Mohammadi, Michael Downes, Ronald M. Evans	2014	192
18	A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis Nature ·Johan W. Jonker, Jae Myoung Suh, Annette R. Atkins, Maryam Ahmadian, Pingping Li, Jamie Whyte, Ming‐Xiao He, Henry Juguilon, Yunqiang Yin, Colin T. Phillips, Ruth T. Yu, Jerrold M. Olefsky, Robert R. Henry, Michael Downes, Ronald M. Evans	2012	223
19	Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX American Journal of Physiology-Cell Physiology ·Johan W. Jonker, Le Thi Kim Chung, Maria L.H. Vlaming, Torsten Plösch, You Nan Guo, M. J. X. Hillebrand, Hilde Rosing, Jos H. Beijnen, Henkjan J. Verkade, Alfred H. Schinkel	2007	26
20	TRANSPORT OF ANTHELMINTIC BENZIMIDAZOLE DRUGS BY BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) Drug Metabolism and Disposition ·Gracia Merino, Johan W. Jonker, Els Wagenaar, Mivis M. Pulido, Antonio J. Molina, Ana I. Álvarez, Alfred H. Schinkel	2005	105

About Johan W. Jonker

Johan W. Jonker is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Biochemistry, Physiology and Endocrinology, Diabetes and Metabolism, having authored 102 papers that have together received 10.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (43 papers), Pharmacological Effects and Toxicity Studies (21 papers), Liver Disease Diagnosis and Treatment (14 papers), Adipose Tissue and Metabolism (13 papers), Fibroblast Growth Factor Research (9 papers), Pediatric Hepatobiliary Diseases and Treatments (9 papers), Pancreatic function and diabetes (8 papers) and Cholesterol and Lipid Metabolism (7 papers). The work is most often cited by research in Oncology (5.0k citations), Pediatrics, Perinatology and Child Health (2.3k citations), Pharmacology (758 citations), Endocrine and Autonomic Systems (496 citations) and Aging (117 citations). Johan W. Jonker has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Alfred H. Schinkel, Els Wagenaar, Michael Downes, Gracia Merino, Antonius E. van Herwaarden, Ronald M. Evans, Jos H. Beijnen, Ruth T. Yu, Hiroyuki Kusuhara and Yuichi Sugiyama. Their work appears in journals such as Scientific Reports, Proceedings of the National Academy of Sciences, Nature, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact